Engineering modification of human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorates polycystic ovary syndrome by enhancing the ovarian environment and regulating follicular development
Abstract
Background: Polycystic Ovary Syndrome (PCOS), is a complex endocrine disorder affecting 6-21% of reproductive-aged women, characterized by chronic anovulation, hyperandrogenism, and polycystic ovarian morphology. Current clinical management relies on lifestyle modifications and symptom-targeted therapies due to the absence of curative interventions. In recent years, Laparoscopic ovarian drilling (LOD), a surgical procedure that induces controlled ovarian damage to stimulate primordial follicle activation and regulate follicular growth, has emerged as an established therapeutic intervention for infertility in PCOS. Beyond surgical approaches, the 740Y-P peptide-PI3K-Akt pathway agonist can achieve similar effects to LOD in enhancing follicular activation and restoring fertility. However, translating 740Y-P into clinical practice remains challenging due to systemic delivery limitations, including poor bioavailability and inadequate ovarian targeting. To address this, naturally secreted sEVs have gained attention as versatile therapeutic vectors owing to their intrinsic immunomodulatory properties and homing tendency.
Methods: In this study, We engineered HucMSC-sEVs through anchor peptide-mediated surface Connections to deliver the 740Y-P peptide. The N-terminus of 740Y-P was conjugated to the C-terminus of the CD63-binding anchor peptide, enabling exogenous loading via co-incubation (4 °C, 12h). Engineered sEVs were characterized for peptide loading efficiency and targeting…
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.